JEFFREY BENSON: Open Payments
NPI 1679933584 · MCALESTER, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$288 in 15 payments from 7 companies in 2025. Trend: 2023 $972 · 2024 $485 · 2025 $288
Food & beverage: $288
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 3 | $77 |
| Lilly USA, LLC | 4 | $72 |
| AstraZeneca Pharmaceuticals LP | 4 | $65 |
| Seqirus USA Inc | 1 | $26 |
| Phathom Pharmaceuticals, Inc. | 1 | $16 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
| Exact Sciences Corporation | 1 | $16 |
Products named: GEMTESA, MOUNJARO, AIRSUPRA, Fluad, JARDIANCE, VOQUEZNA, XIFAXAN, The Cologuard Plus Collection Kit.
Industry payments across OK — which companies pay providers there.
